Sex-based differences in vascular repair with bone marrow cell therapy: relevance of regulatory and Th2-type

A G Zenovich1, A Panoskaltsis-Mortari, G J Caron

  • 1Center for Cardiovascular Repair, Section of Pediatric Bone Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.

Insights

Female bone marrow mononuclear cells (BM-MNCs) protected male mice from atherosclerosis. However, BM-MNCs did not reduce plaque in female mice, suggesting sex-based differences in cell therapy for coronary artery disease (CAD).

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Regenerative Medicine

Background:

  • Coronary artery disease (CAD) exhibits sex-based differences in symptoms and treatment efficacy.
  • Clinical outcomes of cell therapy for CAD are variable.
  • The impact of sex on cell therapy response in CAD remains unclear.

Purpose of the Study:

  • To investigate sex-specific differences in the efficacy of bone marrow mononuclear cells (BM-MNCs) for treating atherosclerosis.
  • To explore the role of sex in response to cell therapy in a mouse model of atherosclerosis.

Main Methods:

  • Atherosclerotic apolipoprotein E-knockout (ApoE-/-) mice of both sexes received intravenous injections of male or female BM-MNCs or vehicle.
  • Aortic plaque burden was quantified.
  • Bone marrow progenitor cell profiles and circulating cytokine levels were analyzed.

Main Results:

  • Female BM-MNCs demonstrated atheroprotective effects in male ApoE-/- mice.
  • No significant reduction in plaque lesions was observed in female ApoE-/- mice treated with BM-MNCs from either sex.
  • Increased levels of granulocyte-colony stimulating factor (G-CSF) correlated with reduced plaque burden.

Conclusions:

  • Sex-based differences exist in the atheroprotective response to BM-MNC therapy.
  • Female BM-MNCs may hold potential for treating atherosclerosis in males.
  • Further research is needed to understand the mechanisms underlying sex differences in vascular repair and cell therapy for CAD.
Abstract

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...